Diagnostic yield of cystic fibrosis from a South Australian monocentric cohort: a retrospective study

Objectives To determine the diagnostic yield of cystic fibrosis (CF) using a two-tiered genetic testing approach. Although newborn screening includes CF, this typically only covers a selection of common genetic variants, and with over 2000 reported in the cystic fibrosis transmembrane conductance re...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Fuller, Jasmina Markulić
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/1/e092209.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832543440584310784
author Maria Fuller
Jasmina Markulić
author_facet Maria Fuller
Jasmina Markulić
author_sort Maria Fuller
collection DOAJ
description Objectives To determine the diagnostic yield of cystic fibrosis (CF) using a two-tiered genetic testing approach. Although newborn screening includes CF, this typically only covers a selection of common genetic variants, and with over 2000 reported in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, we hypothesised that patients will be missed and present clinically later in life.Design A retrospective study over a 5-year period (January 2018–December 2022).Setting A single pathology service in South Australia.Participants A total of 1909 CF test referrals from patients with clinical suspicion indicated by respiratory and gastrointestinal manifestations, foetal echogenic bowel and male infertility and asymptomatic CF requests for reproductive carrier screening.Primary and secondary outcome measures The number and type of CFTR gene variants detected in symptomatic and asymptomatic testing referrals.Results A total of 25 patients were diagnosed with CF or CF-related disorders (2.5%) with gastrointestinal symptoms yielding the highest diagnostic rate of 4.4%. Additionally, a total of 79 carriers (4.1%) were identified uncovering a carrier frequency of 1 in 24, which is consistent with the 1 in 25 reported in the Caucasian population. CF was found to be causative of foetal echogenic bowel in 0.83% of cases.Conclusions This study highlights the importance of considering CF in symptomatic patients, even in a nation with >99% of newborns screened for CF. Additionally, the identification of CF in this population supports the recommendation for CF genetic testing in reproductive healthcare.
format Article
id doaj-art-96f131717e02483489321be8817bd713
institution Kabale University
issn 2044-6055
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-96f131717e02483489321be8817bd7132025-02-03T11:45:11ZengBMJ Publishing GroupBMJ Open2044-60552025-01-0115110.1136/bmjopen-2024-092209Diagnostic yield of cystic fibrosis from a South Australian monocentric cohort: a retrospective studyMaria Fuller0Jasmina Markulić11 Genetics and Molecular Pathology, SA Pathology at Women`s and Children`s Hospital, North Adelaide, South Australia, Australia1 Genetics and Molecular Pathology, SA Pathology, North Adelaide, South Australia, AustraliaObjectives To determine the diagnostic yield of cystic fibrosis (CF) using a two-tiered genetic testing approach. Although newborn screening includes CF, this typically only covers a selection of common genetic variants, and with over 2000 reported in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, we hypothesised that patients will be missed and present clinically later in life.Design A retrospective study over a 5-year period (January 2018–December 2022).Setting A single pathology service in South Australia.Participants A total of 1909 CF test referrals from patients with clinical suspicion indicated by respiratory and gastrointestinal manifestations, foetal echogenic bowel and male infertility and asymptomatic CF requests for reproductive carrier screening.Primary and secondary outcome measures The number and type of CFTR gene variants detected in symptomatic and asymptomatic testing referrals.Results A total of 25 patients were diagnosed with CF or CF-related disorders (2.5%) with gastrointestinal symptoms yielding the highest diagnostic rate of 4.4%. Additionally, a total of 79 carriers (4.1%) were identified uncovering a carrier frequency of 1 in 24, which is consistent with the 1 in 25 reported in the Caucasian population. CF was found to be causative of foetal echogenic bowel in 0.83% of cases.Conclusions This study highlights the importance of considering CF in symptomatic patients, even in a nation with >99% of newborns screened for CF. Additionally, the identification of CF in this population supports the recommendation for CF genetic testing in reproductive healthcare.https://bmjopen.bmj.com/content/15/1/e092209.full
spellingShingle Maria Fuller
Jasmina Markulić
Diagnostic yield of cystic fibrosis from a South Australian monocentric cohort: a retrospective study
BMJ Open
title Diagnostic yield of cystic fibrosis from a South Australian monocentric cohort: a retrospective study
title_full Diagnostic yield of cystic fibrosis from a South Australian monocentric cohort: a retrospective study
title_fullStr Diagnostic yield of cystic fibrosis from a South Australian monocentric cohort: a retrospective study
title_full_unstemmed Diagnostic yield of cystic fibrosis from a South Australian monocentric cohort: a retrospective study
title_short Diagnostic yield of cystic fibrosis from a South Australian monocentric cohort: a retrospective study
title_sort diagnostic yield of cystic fibrosis from a south australian monocentric cohort a retrospective study
url https://bmjopen.bmj.com/content/15/1/e092209.full
work_keys_str_mv AT mariafuller diagnosticyieldofcysticfibrosisfromasouthaustralianmonocentriccohortaretrospectivestudy
AT jasminamarkulic diagnosticyieldofcysticfibrosisfromasouthaustralianmonocentriccohortaretrospectivestudy